E. Roy Berger
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Prostate Cancer Treatment and Research 4
- Prostate Cancer Diagnosis and Treatment 3
- Blood properties and coagulation 1
- Vascular Procedures and Complications 1
-
- Hemophilia Treatment and Research 2
- Platelet Disorders and Treatments 2
- Co-authors
- Neal D. Shore (3 shared papers)Robert Dreicer (1 shared paper)Yi Xu (1 shared paper)Charles H. Redfern (1 shared paper)Robert B. Sims (1 shared paper)Paul F. Schellhammer (1 shared paper)Philip W. Kantoff (1 shared paper)Mark W. Frohlich (1 shared paper)
- Journals
- Blood (2 papers)Urology (2 papers)Annals of Surgery (1 paper)New England Journal of Medicine (1 paper)Experimental Cell Research (1 paper)
- Partner nations
- United States
In The Last Decade
E. Roy Berger
10 papers receiving 4.4k citations
E. Roy Berger's Hit Papers
Peers
Comparison fields: 5 of 97
- Immunology 2.0k
- Oncology 2.0k
- Pulmonary and Respiratory Medicine 1.7k
- Cancer Research 422
- Radiology, Nuclear Medicine and Imaging 440
Countries citing papers authored by E. Roy Berger
This map shows the geographic impact of E. Roy Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Roy Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Roy Berger more than expected).
Fields of papers citing papers by E. Roy Berger
This network shows the impact of papers produced by E. Roy Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Roy Berger. The network helps show where E. Roy Berger may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Roy Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer Hit paper breakdown → | 2010 | 4127 |
| 2 | 1996 | 149 | |
| 3 | 2014 | 76 | |
| 4 | 1981 | 61 | |
| 5 | 1974 | 41 | |
| 6 | Prostate Cancer Awareness Week, 1992: a summary of key findings. | 1993 | 23 |
| 7 | 1975 | 7 | |
| 8 | 1981 | 3 | |
| 9 | 2005 | 2 | |
| 10 | 2007 | 1 |
About E. Roy Berger
E. Roy Berger is a scholar working on Pulmonary and Respiratory Medicine, Hematology, Nephrology, Genetics and Aquatic Science, having authored 10 papers that have together received 4.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Hemophilia Treatment and Research (2 papers), Platelet Disorders and Treatments (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Blood properties and coagulation (1 paper), Vascular Procedures and Complications (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Immunology (2.0k citations), Oncology (2.0k citations), Pulmonary and Respiratory Medicine (1.7k citations), Cancer Research (422 citations) and Radiology, Nuclear Medicine and Imaging (440 citations). E. Roy Berger has collaborated with scholars based in United States. Frequent co-authors include Neal D. Shore, Robert Dreicer, Yi Xu, Charles H. Redfern, Robert B. Sims, Paul F. Schellhammer, Philip W. Kantoff, Mark W. Frohlich, Anna C. Ferrari and Eric J. Small. Their work appears in journals such as Blood, Urology, Annals of Surgery, New England Journal of Medicine and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.